New Feature Coming Soon, Stay Tuned!
Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.
OTC
Unprofitable
EPS improving
Unprofitable
EPS improving
-0.00Â ( -0.37%)
Pre-market NaN$
0.00 (0.00%)
Relative Strenght
Volume Buzz
-98%
Earning Acce
No
Dist 52w H.
4%